Rifaximin-treatment of Collagenous Colitis

Clinical trial NCT03658993 · UNKNOWN

Trial details

NCT number: NCT03658993
Sponsor: Bonderup, Ole K., M.D.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Collagenous Colitis

Start date: 2018-11-01
Primary completion: 2020-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.